Cancer treatment with mta-cooperated PRMT5

CN119317435APending Publication Date: 2025-01-14AMGEN INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380045230.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-05-25
Filing Date
2023-04-07
Publication Date
2025-01-14

Smart Images

  • Figure CN119317435A_ABST
    Figure CN119317435A_ABST
Patent Text Reader

Abstract

Described herein are methods of treating cancer in a patient comprising administering a PRMT5 inhibitor. Also provided are methods of treating cancer in a patient comprising administering a PRMT5 inhibitor and a standard therapeutic therapy.
Need to check novelty before this filing date? Find Prior Art